- Home
- IMPP vs SGMO Comparison
IMPP vs SGMO Comparison
Compare IMPP & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMPP
- SGMO
- Stock Information
- Founded
- IMPP 1981
- SGMO 1995
- Country
- IMPP Greece
- SGMO United States
- Employees
- IMPP N/A
- SGMO N/A
- Industry
- IMPP Marine Transportation
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IMPP Consumer Discretionary
- SGMO Health Care
- Exchange
- IMPP Nasdaq
- SGMO Nasdaq
- Market Cap
- IMPP 103.9M
- SGMO 122.8M
- IPO Year
- IMPP N/A
- SGMO 2000
- Fundamental
- Price
- IMPP $3.10
- SGMO $0.53
- Analyst Decision
- IMPP
- SGMO Buy
- Analyst Count
- IMPP 0
- SGMO 6
- Target Price
- IMPP N/A
- SGMO $4.50
- AVG Volume (30 Days)
- IMPP 382.8K
- SGMO 5.9M
- Earning Date
- IMPP 08-26-2025
- SGMO 08-05-2025
- Dividend Yield
- IMPP N/A
- SGMO N/A
- EPS Growth
- IMPP N/A
- SGMO N/A
- EPS
- IMPP 1.21
- SGMO N/A
- Revenue
- IMPP $138,368,325.00
- SGMO $63,756,000.00
- Revenue This Year
- IMPP $8.79
- SGMO N/A
- Revenue Next Year
- IMPP $40.11
- SGMO N/A
- P/E Ratio
- IMPP $2.56
- SGMO N/A
- Revenue Growth
- IMPP N/A
- SGMO 239.92
- 52 Week Low
- IMPP $2.12
- SGMO $0.30
- 52 Week High
- IMPP $4.55
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- IMPP 51.26
- SGMO 49.93
- Support Level
- IMPP $3.02
- SGMO $0.50
- Resistance Level
- IMPP $3.16
- SGMO $0.61
- Average True Range (ATR)
- IMPP 0.23
- SGMO 0.05
- MACD
- IMPP -0.05
- SGMO 0.01
- Stochastic Oscillator
- IMPP 10.39
- SGMO 58.45
About IMPP Imperial Petroleum Inc.
Imperial Petroleum Inc is a provider of international seaborne transportation services to oil producers, refineries, and commodities traders. It owns and operates a fleet of six medium-range product tankers that carry refined petroleum products such as gasoline, diesel, fuel oil, and jet fuel, as well as edible oils and chemicals.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.